dc.contributor.author
Karow, Fabian
dc.contributor.author
Smiljanovic, Biljana
dc.contributor.author
Grün, Joachim R.
dc.contributor.author
Poddubnyy, Denis
dc.contributor.author
Proft, Fabian
dc.contributor.author
Talpin, Alice
dc.contributor.author
Hue, Christophe
dc.contributor.author
Boland, Anne
dc.contributor.author
Deleuze, Jean-François
dc.contributor.author
Garchon, Henri-Jean
dc.contributor.author
Ergenç, Ilkay
dc.contributor.author
De Craemer, Ann-Sophie
dc.contributor.author
Erben, Ulrike
dc.contributor.author
Häupl, Thomas
dc.contributor.author
Elewaut, Dirk
dc.contributor.author
Breban, Maxime
dc.contributor.author
Grützkau, Andreas
dc.contributor.author
Syrbe, Uta
dc.date.accessioned
2023-03-17T15:23:32Z
dc.date.available
2023-03-17T15:23:32Z
dc.identifier.uri
https://refubium.fu-berlin.de/handle/fub188/38450
dc.identifier.uri
http://dx.doi.org/10.17169/refubium-38168
dc.description.abstract
Background: In patients with axial spondyloarthritis (axSpA), monocytes show a pre-activated phenotype. Gut inflammation is a trigger of monocyte activation and may also affect their development in the bone marrow (BM). As gut inflammation is commonly observed in axSpA patients, we performed a detailed analysis of monocyte transcriptomes of axSpA patients in two cohorts and searched for signs of activation and developmental adaptations as putative imprints of gut inflammation.
Methods: Transcriptomes of blood CD14(+) monocytes of HLA-B27+ axSpA patients and healthy controls (HC) were generated by microarrays from cohort 1 and by RNA-sequencing from cohort 2. Differentially expressed genes from both analyses were subjected to gene set enrichment analysis (GSEA) and to co-expression analysis in reference transcriptomes from BM cells, blood cells and activated monocytes. As serological markers of translocation, 1,3 beta-glycan, intestinal fatty acid binding protein, and lipopolysaccharide binding protein (LBP) were determined by LAL and ELISA.
Results: Transcriptome analysis identified axSpA-specific monocyte signatures showing an imprint of LPS/cytokine-activated monocytes, late granulopoietic BM cells, blood neutrophils, and G-CSF-mobilized blood cells, which suggests LPS/TNF activation and more prominent BM adaptation promoting a neutrophil-like phenotype. GSEA mapped axSpA upregulated genes to inflammatory responses and TNF alpha signaling and downregulated probe-sets to metabolic pathways. Among translocation markers, LBP levels were significantly increased in axSpA patients vs. HC (p < 0.001). Stratified analysis by disease activity and stage identified an "active disease signature" (BASDAI >= 4) with an imprint of LPS/cytokine-activated monocytes and CD16(+) monocyte subsets. The "AS signature" (vs. non-radiographic axSpA) showed a reinforced neutrophil-like phenotype due to deprivation of dendritic cell transcripts.
Conclusions: The neutrophil-like phenotype of axSpA monocytes points towards a biased monocytopoiesis from granulocyte-monocyte progenitors. This shift in monocytopoiesis and the LPS/cytokine imprint as well as the elevated LBP levels are indicators of systemic inflammation, which may result from bacterial translocation. The BM adaptation is most prominent in AS patients while disease activity appears to be linked to activation and trafficking of monocytes.
en
dc.rights.uri
https://creativecommons.org/licenses/by/4.0/
dc.subject
Spondyloarthritis
en
dc.subject
Transcriptomes
en
dc.subject
Gut translocation
en
dc.subject.ddc
600 Technik, Medizin, angewandte Wissenschaften::610 Medizin und Gesundheit::610 Medizin und Gesundheit
dc.title
Monocyte transcriptomes from patients with axial spondyloarthritis reveal dysregulated monocytopoiesis and a distinct inflammatory imprint
dc.type
Wissenschaftlicher Artikel
dcterms.bibliographicCitation.articlenumber
246
dcterms.bibliographicCitation.doi
10.1186/s13075-021-02623-7
dcterms.bibliographicCitation.journaltitle
Arthritis Research & Therapy
dcterms.bibliographicCitation.originalpublishername
Springer Nature
dcterms.bibliographicCitation.volume
23
refubium.affiliation
Charité - Universitätsmedizin Berlin
refubium.funding
Springer Nature DEAL
refubium.resourceType.isindependentpub
no
dcterms.accessRights.openaire
open access
dcterms.bibliographicCitation.pmid
34560894
dcterms.isPartOf.eissn
1478-6362